China Universal Asset Management Co., Ltd. Abcam PLC Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$21.54 - $24.41 $55,163 - $62,514	2,561 Added 86.75%	5,513 $124,000
Q3 2023 Oct 30, 2023	BUY	$21.54 - $24.41 $55,163 - $62,514	2,561 Added 86.75%	5,513 $125,000
Q2 2023 May 21, 2024	BUY	$12.62 - $24.47 $681 - $1,321	54 Added 1.86%	2,952 $72,000
Q2 2023 Jul 27, 2023	BUY	$12.62 - $24.47 $681 - $1,321	54 Added 1.86%	2,952 $72,000
Q1 2023 May 21, 2024	BUY	$12.98 - $17.1 $33,527 - $44,169	2,583 Added 820.0%	2,898 $39,000
Q1 2023 Apr 27, 2023	BUY	$12.98 - $17.1 $33,527 - $44,169	2,583 Added 820.0%	2,898 $39,000
Q4 2022 May 21, 2024	BUY	$13.92 - $17.0 $4,384 - $5,355	315 New	315 $4,000
Q4 2022 Jan 31, 2023	BUY	$13.92 - $17.0 $1,016 - $1,241	73 Added 30.17%	315 $5,000
Q3 2022 Oct 21, 2022	BUY	$13.36 - $16.75 $3,233 - $4,053	242 New	242 $4,000

Others Institutions Holding ABCM

# of Institutions

Shares Held

1.03M

Call Options Held

Put Options Held

View Full List

About Abcam plc

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

More about ABCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account